Nextel Medical Corp. (MAJI) stock: key figures, P/E, revenue and dividend
Communication Services · United States · ISIN US36257K2087
Nextel Medical Corp. financials
| Fiscal year | 2026 |
|---|---|
| Revenue | 500.00 USD |
| Gross profit | -173,070.00 USD |
| Operating income | -508,734.00 USD |
| Net income | 13.52 m USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Nextel Medical Corp.
Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.
More stocks
- Fyntechnical Innovations Inc (FYNN)
- FOXO TECHNOLOGIES INC. (FOXO)
- AMAZE HOLDINGS, INC. (AMZE)
- Maison Solutions Inc. (MSS)
- 1606 CORP. (CBDW)
- Awareness Group, Inc. (TAAG)
- Tanke Biosciences Corp (TNBI)
- Cardiff Lexington Corp (CDIX)
- MOBIX LABS, INC (MOBX)
- Longevity Health Holdings, Inc. (XAGE)
- ADVANCED OXYGEN TECHNOLOGIES INC (AOXY)
- ENCISION INC (ECIA)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.